Modification of anti-tumor immunity by tolerogenic dendritic cells

Autoimmunity

Volumn 50, Issue 6, 2017, Pages 370-376

  Chen, Liying ^a   Hasni, Mohammad Sharif ^a   Jondal, Mikael ^a   Yakimchuk, Konstantin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

anti tumor immune response; Dendritic cells; glucocorticoids; NK cells; T cells

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CD69 ANTIGEN; GAMMA INTERFERON; GLUCOCORTICOID; HERMES ANTIGEN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3; CD11B ANTIGEN; CD44 PROTEIN, MOUSE; DEXAMETHASONE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; HYALURONIC ACID BINDING PROTEIN; IL10 PROTEIN, MOUSE; LECTIN; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; OLIGODEOXYRIBONUCLEOTIDE; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MODEL; ADOPTIVE TRANSFER; ANIMAL; CELL COMMUNICATION; DRUG EFFECT; GENE EXPRESSION; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; LYMPHOMA; PATHOLOGY; REGULATORY T LYMPHOCYTE; TRANSPLANTATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD8-POSITIVE T-LYMPHOCYTES; CELL COMMUNICATION; DENDRITIC CELLS; DEXAMETHASONE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; GLUCOCORTICOIDS; HYALURONAN RECEPTORS; IMMUNE TOLERANCE; INTERFERON-GAMMA; INTERLEUKIN-10; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; LYMPHOMA; MACROPHAGE-1 ANTIGEN; MICE; MICE, KNOCKOUT; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

EID: 85021785718     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916934.2017.1344837     Document Type: Article

References (42)

1. Ayroldi E, Cannarile L, Migliorati G, et al. Mechanisms of the anti-inflammatory effects of glucocorticoids:genomic and nongenomic interference with MAPK signaling pathways. FASEB J. 2012;26:4805–4820.
2. Coutinho AE, Chapman KE., The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol. 2011;335:2–13.
3. Strehl C, Buttgereit F., Optimized glucocorticoid therapy:teaching old drugs new tricks. Mol Cell Endocrinol. 2013;380:32–40.
4. Meijsing SH., Mechanisms of glucocorticoid-regulated gene transcription. Adv Exp Med Biol. 2015;872:59–81.
5. Vandevyver S, Dejager L, Libert C., Comprehensive overview of the structure and regulation of the glucocorticoid receptor. Endocr Rev. 2014;35:671–693.
6. Lu NZ, Cidlowski JA., Glucocorticoid receptor isoforms generate transcription specificity. Trend Cell Biol. 2006;16:301–307.
7. Petta I, Dejager L, Ballegeer M, et al. The interactome of the glucocorticoid receptor and its influence on the actions of glucocorticoids in combatting inflammatory and infectious diseases. Microbiol Mol Biol Rev. 2016;80:495–522.
8. Rozkova D, Horvath R, Bartunkova J, et al. Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. Clin Immunol. 2006;120:260–271.
9. Piemonti L, Monti P, Allavena P, et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol. 1999;162:6473–6481.
10. Butts CL, Shukair SA, Duncan KM, et al. Effects of dexamethasone on rat dendritic cell function. Horm Metab Res. 2007;39:404–412.
11. Pan J, Ju D, Wang Q, et al. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway. Immunol Lett. 2001;76:153–161.
12. Adler HS, Steinbrink K., Tolerogenic dendritic cells in health and disease:friend and foe! Eur J Dermatol. 2007;17:476–491. Epub 2007/10/24.
13. Ashwell JD, Lu FW, Vacchio MS., Glucocorticoids in T cell development and function*. Annu Rev Immunol. 2000;18:309–345.
14. Erlacher M, Knoflach M, Stec IE, et al. TCR signaling inhibits glucocorticoid-induced apoptosis in murine thymocytes depending on the stage of development. Eur J Immunol. 2005;35:3287–3296.
15. Yakimchuk K, Chen L, Hasni MS, et al. The selective impact of transgenically expressed glucocorticoid receptor on T cells. Autoimmunity. 2015;48:117–124.
16. Braitch M, Harikrishnan S, Robins RA, et al. Glucocorticoids increase CD4CD25 cell percentage and Foxp3 expression in patients with multiple sclerosis. Acta Neurol Scand. 2009;119:239–245.
17. Karagiannidis C, Akdis M, Holopainen P, et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol. 2004;114:1425–1433.
18. Zhou X, Kong N, Zou H, et al. Therapeutic potential of TGF-beta-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases. Autoimmunity. 2011;44:43–50.
19. Harry RA, Anderson AE, Isaacs JD, et al. Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann Rheum Dis. 2010;69:2042–2050.
20. Dinesh RK, Skaggs BJ, La Cava A, et al. CD8+ Tregs in lupus, autoimmunity, and beyond. Autoimmun Rev. 2010;9:560–568.
21. Tsai S, Clemente-Casares X, Santamaria P., CD8(+) Tregs in autoimmunity:learning “self”-control from experience. Cell Mol Life Sci. 2011;68:3781–3795.
22. Gajewski TF, Schreiber H, Fu YX., Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14:1014–1022.
23. Galetto G, Law LW, Rogers MJ., The Rauscher-MuLV-induced leukemia, RBL-5, bears two tumor-associated transplantation antigens expressed on distinct molecules. Int J Cancer. 1985;36:713–719.
24. Zhou F, Rouse BT, Huang L., Prolonged survival of thymoma-bearing mice after vaccination with a soluble protein antigen entrapped in liposomes:a model study. Cancer Res. 1992;52:6287–6291.
25. Trinchieri G., Biology of natural killer cells. Adv Immunol. 1989;47:187–376.
26. Spallanzani RG, Torres NI, Avila DE, et al. Regulatory dendritic cells restrain NK cell IFN-gamma production through mechanisms involving NKp46, IL-10, and MHC class I-specific inhibitory receptors. J Immunol. 2015;195:2141–2148.
27. Chiossone L, Chaix J, Fuseri N, et al. Maturation of mouse NK cells is a 4-stage developmental program. Blood. 2009;113:5488–5496.
28. Girardi M, Oppenheim DE, Steele CR, et al. Regulation of cutaneous malignancy by gammadelta T cells. Science. 2001;294:605–609.
29. Hayakawa Y, Kelly JM, Westwood JA, et al. Cutting edge:tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin. J Immunol. 2002;169:5377–5381.
30. Rifa'i M, Kawamoto Y, Nakashima I, et al. Essential roles of CD8 + CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med. 2004;200:1123–1134.
31. Endharti AT, Rifa IM, Shi Z, et al. Cutting edge:CD8 + CD122+ regulatory T cells produce IL-10 to suppress IFN-gamma production and proliferation of CD8+ T cells. J Immunol. 2005;175:7093–7097.
32. Levings MK, Gregori S, Tresoldi E, et al. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25 + CD4+ Tr cells. Blood. 2005;105:1162–1169.
33. Jonuleit H, Schmitt E, Schuler G, et al. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 2000;192:1213–1222.
34. Zhou F, Ciric B, Zhang GX, et al. Immunotherapy using lipopolysaccharide-stimulated bone marrow-derived dendritic cells to treat experimental autoimmune encephalomyelitis. Clinical and experimental. Clin Exp Immunol. 2014;178:447–458.
35. Mayer CT, Floess S, Baru AM, et al. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity. Eur J Immunol. 2011;41:716–725.
36. Wang LX, Li Y, Yang G, et al. CD122 + CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice. Eur J Immunol. 2010;40:1375–1385.
37. Chaput N, Louafi S, Bardier A, et al. Identification of CD8 + CD25 + Foxp3+ suppressive T cells in colorectal cancer tissue. Gut. 2009;58:520–529.
38. Kiniwa Y, Miyahara Y, Wang HY, et al. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer. Clin Cancer Res. 2007;13:6947–6958.
39. Lourenco EV, La Cava A., Natural regulatory T cells in autoimmunity. Autoimmunity. 2011;44:33–42.
40. Ohkura N, Sakaguchi S., Maturation of effector regulatory T cells. Nat Immunol. 2011;12:283–284.
41. Cretney E, Xin A, Shi W, et al. The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells. Nat Immunol. 2011;12:304–311.
42. Rogatsky I, Chandrasekaran U, Manni M, et al. Epigenetics and the IRFs:a complex interplay in the control of immunity and autoimmunity. Autoimmunity. 2014;47:242–255.